Adrian Holloway

Adrian Holloway is the senior editor of Plastic Surgery Exit Report, an independent publication for surgeons who own aesthetic and reconstructive plastic surgery practices. He writes about a decision most surgeons make only once: whether to sell, partner with a private equity-backed group, bring in an associate as a successor, or keep practicing independently.

His readers built their practices one patient at a time. Many have spent twenty years or more developing a reputation, a surgical team and, often, their own accredited operating room. Most have never sold a business. Adrian’s job is to explain how the market works, what buyers really pay for and which deal terms matter, in plain English, before the first offer arrives.

What he covers

• How to sell a plastic surgery practice, from preparation to closing
• Plastic surgery practice valuation, EBITDA multiples and goodwill
• Who buys plastic surgery practices, from private equity platforms to surgeon buyers
• Rollover equity, earnouts, employment agreements and non-competes
• Consolidation trends, platform sales and what they mean for independent surgeons

How he reports

Adrian works from primary and named sources: procedure data from professional societies, published transaction benchmarks from healthcare investment banks, tax and legal analysis from established firms, and state laws and enforcement actions. His standards are simple:

• Every statistic links to its source. If a number can’t be traced, it doesn’t run.
• Examples are labeled. Illustrative figures are marked as hypothetical, never presented as real deals.
• Articles are dated and updated. Each guide shows when it was last reviewed.
• The partnership is disclosed. Plastic Surgery Exit Report is published in partnership with Olympic M&A, a healthcare M&A advisory firm, and every article says so.
• It’s information, not advice. Guides that touch on tax, law or finance say so, and point readers to their own advisers.

Why this beat

Private equity groups, management services organizations and platform buyers approach surgeons with experienced deal teams and years of transaction data. Most surgeons walk into those conversations with neither. Adrian thinks surgeon-owners deserve the same quality of information the buyers already have, so they can decide on their own terms, whether that means selling, partnering or staying independent.